Homology modeling of γ-inobutyrateaminotransferase, a pyridoxal phosphate-dependent enzyme of homo sapiens: Molecular modeling approach to rational drug design against epilepsy

African Journal of Biotechnology

Volumn 10, Issue 31, 2011, Pages 5916-5926

  Khan, Hina Naz ^a   Rashid, Hamid ^a   Kulsoom, Saima ^b  

^a CAPITAL UNIVERSITY OF SCIENCE AND TECHNOLOGY   (Pakistan)

^b QUAID I AZAM UNIVERSITY   (Pakistan)

Author keywords

aminobutyrate aminotransferase (GABA AT); Blast; Crystal structure; Epilepsy; Homology modeling; Template

Indexed keywords

4 AMINOBUTYRATE AMINOTRANSFERASE;

ANIMAL TISSUE; ARTICLE; CONTROLLED STUDY; DRUG DESIGN; DRUG DEVELOPMENT; DRUG TARGETING; ENZYME STRUCTURE; EPILEPSY; LIVER; MOLECULAR MODEL; NONHUMAN; PREDICTION; SEQUENCE ALIGNMENT; STRUCTURAL HOMOLOGY; X RAY CRYSTALLOGRAPHY;

HOMO SAPIENS; SUIDAE;

EID: 79960055674     PISSN: 16845315     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (43)

1. Adamczak R, Porollo A, Meller J (2005). Combining Prediction of Secondary Structure and Solvent Accessibility in Proteins. Proteins: Structure, Function Bioinformatics, 59: 467-75.
2. Aoyagi T, Wada T, Nagai M, Kojima F, Harada S, Takeuchi T, Takahashi H, Hirokawa K, Tsumita, T (1990). Increased γ- aminobutyrate aminotransferase activity in brain patients with Alzheimer's disease. Chem. Pharm. Bull., 38: 1748-1749.
3. Bairoch A, Bucher P, Hofmann K (1997). PROSITE: Nucleic Acids Res., 25: 217-221.
4. Bajorath J, Stenkamp R, Aruffo A (1994). Knowledge-based model building of proteins: Concepts and examples. Protein Sci., 2: 1798-1810.
5. Bakay RAE, Harris AB (1981). Neurotransmitter, receptor and biochemical changes in monkey cortical epileptic foci. Brain Res., 206: 387-404.
6. Bell GS, Sander JW (2001). The epidemiology of epilepsy: the size of the problem. Seizure, 10: 306-316.
7. Bloch-Tardy M, Rolland B, Gonnard P (1974). Kinetic and thermodynamic studies with NADH as coenzyme. Biochimie, 56: 823-832.
8. Blundell TL, Sibanda BL, Sternberg MJE, Thornton JM (1987). Knowledge-based prediction of protein structures and the design of novel molecules. Nature, 326: 347-352.
9. Butterworth J, Yates CM, Simpson J (1983). Phosphate-activated glutaminase in relation to Huntington's disease and agonal state. J Neurochem., 41: 440-447
10. Ceroni A, Frasconi P, Passerini A, Vullo A (2004). Disulfide connectivity prediction using recursive neural networks and evolutionary information. Bioinformatics, 20: 653-659.
11. Cole C, Barber JD, Barton GJ (2008). The Jpred 3 secondary structure prediction server. Nucleic Acids Res., 36: 197-201.
12. Cooper AJ (1985). Glutamate-gamma-aminobutyrate transaminase. Methods Enzymol., 113: 80-82.
13. Davies JA (1995). Mechanisms of action of antiepileptic drugs. Seizure, 4: 267-271.
14. De Biase D, Barra D, Simmaco M, John RA, Bossa F (1995). Primary structure and tissue distribution of human 4-aminobutyrate aminotransferase. Eur. J. Biochem., 227: 476-480.
15. Edgar RC (2004). MUSCLE: multiple sequence alignment with high accuracy and high throughput. Nucleic Acids Res., 32(5): 1792-1797.
16. Enyedy I, Lee S, Kuo A., Dickson R, Lin C, Wang S (2001). Structurebased approach for the discovery of bisbenzamidines as novel inhibitors of matriptase. J. Med. Chem., 44: 1349-1355.
17. Greer J (1990). Comparative modelling methods: Application to the family of the mammalian serine proteases. Proteins, 7: 317-334.
18. Gunne LM, Haeggstroem JE, Sjoequist B (1984). Association with persistent neurolepticinduced dyskinesia of regional. Nature, 309: 347-349.
19. Hirokawa T, Boon CS, Mitaku S (1998). SOSUI: classification and secondary structure prediction system for membrane proteins. Bioinformatics, 14: 378-379.
20. Hofmann K, Stoffel W (1993). TMbase - A database of membrane spanning proteins segments. Biol Chem 374: 166-170.
21. Holm L, Sander C (1992). Evaluation of protein models by atomic salvation preference; J. Mol. Biol., 225: 93-105.
22. Jain AN (2004). Virtual screening in lead discovery and optimization. Curr. Opin. Drug Discov. Dev., 7: 396-403.
23. Johnson MS, Srinivasan N, Sowdhamini R, Blundell TL (1994). Knowledge-based protein modelling. CRC Crit. Rev. Biochem. Mol. Biol., 29: 1-68.
24. Kasteleijn-Nolst Trenité DGA, Genton P, Parain D, Masnou P, Steinhoff BJ, Jacobs T (2007). Evaluation of brivaracetam, a novel SV2A ligand, in the photosensitivity model. Neurology, 69: 1027-1034.
25. Krogh A, Larsson B, Von HG, EL Sonnhammer (2001). Predicting transmembrane protein topology with a hidden Markov model: application to complete genomes. J. Mol. Biol., 305: 567-80.
26. Laskowski RA, MacArthur MW, Moss DS, Thornton JM (1993). PROCHECK: a program to check the stereochemical quality of protein structures; J. Appl. Cryst., 26: 283-291.
27. Lippert B, Metcalf BW, Jung M.J, Casara P (1977). 4-amino-hex-5-enoic acid: a selective catalytic inhibitor of 4-aminobutyric acid aminotransferase in mammalian brain. Eur. J. Biochem.,74: 441-445.
28. McGuffin LJ, Bryson K and Jones DT (2000). The PSIPRED protein structure prediction server. Bioinformatics Appl. Note, 16: 404-405.
29. Mehta PK, Christen P (2000). The molecular evolution of pyridoxal-5'- phosphate-dependent enzymes. Adv. Enzymol. Relat. Areas Mol. Biol., 74: 129-184.
30. Mehta PK, Hale TI, Christen P (1993). Aminotransferases: demonstration of homology and division into evolutionary subgroups. Eur. J. Biochem., 214: 549-561.
31. Nishino N, Fujiwara H, Noguchi-Kuno SA, Tanaka C (1988). GABAA receptor but not muscarinic receptor density was decreased in the brain of patients with Parkinson's disease. Jpn. J. Pharmacol., 48: 331-339.
32. Pieper U, Eswar N, Braberg H, Madhusudhan MS, Davis FP, Stuart AC, Mirkovic N, Ossi A, Marti-Renom M, Fiser A, Webb B, Greenblatt D, Huang CC, Ferrin TE, Sali A (2004). MODBASE, a database of annotated comparative protein structure models, and associated resources. Nucleic Acids Res., 32: 217-222.
33. Pieper U, Eswar N, Webb BM, Eramian D, Kelly L, Barkan DT, Carter H, Mankoo P, Karchin R, Marti-Renom MA, Davis FP and Sali A (2009). MODBASE, a database of annotated comparative protein structure models and associated resources. Nucleic Acids Res., 37:347-354.
34. Puntervoll P, Linding R, Gemünd C, Chabanis DS, Mattingsdal M, et al. (2003). ELM server: a new resource for investigating short functional sites in modular eukaryotic proteins. Nucleic Acids Res., 31: 3625-3630.
35. Rogawski MA, Porter RJ (1990). Antiepileptic drugs: pharmacological mechanisms and clinical efficacy with consideration of promising developmental stage compounds. Pharmacol. Rev., 42: 223-286.
36. Rost B, Yachdav G, Liu J (2004). The PredictProtein Server. Nucleic Acids Res., 32: 321-326.
37. Sali A (1995). Modelling mutations and homologous proteins. Curr. Opin. Biotech., 6: 437-451.
38. Sali A, Blundell TL (1993). Comparative protein modelling by satisfaction of spatial restrainsts; J. Mol. Biol., 234: 779-815.
39. Sanchez R, Sali A (1997). Advances in comparative protein-structure modeling. Curr. Opin. Struct. Biol., 7: 206-214.
40. Shankar R, Frapaise X, Brown B (2006). LEAN drug development in R&D. Drug Discov Dev., pp. 57-60.
41. Stoermer MJ (2006). Current status of virtual screening as analysed by target class. Med. Chem., 2: 89-112.
42. Storici P, Qiu J, Schirmer T, Silverman RB (2004). Mechanistic crystallography. Mechanism of inactivation of gamma-aminobutyric acid aminotransferase by (1R,3S,4S)-3-amino-4-fluorocyclopentane- 1-carboxylic acid as elucidated by crystallography. Biochemistry, 43(44): 14057-14063.
43. Thompson JD, Higgins DG, Gibson TJ (1994). CLUSTAL W: improving the sensitivity of progressive multiple sequence alignment through sequence weighting, position-specific gap penalties and weight matrix choice. Nucleic Acids Res., 22: 4673-4680.